Study of the Macular Pigment by the Consumption of Corn With Strong Content in Zeaxanthine
- Conditions
- Age Macular Degeneration
- Interventions
- Other: Corn zeaxanthin
- Registration Number
- NCT02113254
- Lead Sponsor
- University Hospital, Bordeaux
- Brief Summary
The Age Macular Degeneration (AMD) is the first cause of blindness in industrialized countries. The macular pigment (lutein and zeaxanthin) could play an important role in the arisen of the AMD. The food supplementation by corn with strong concentration in macular pigment could increase the density of the macular pigment. This could, in the future, represent a strategy of prevention of the AMD. The main objective of this study is to detect an increase of the macular pigment density after the consumption of this corn at healthy volunteers.
- Detailed Description
The age macular degeneration represents the first cause of blindness in industrialized countries if it is not treated. In France, the AMD affects 600 000 persons and this figure should continue to increase, notably because of the increase of the life expectancy. The macula is responsible of the fine vision, the vision of colours and the perception of contrasts. The macular pigment is present only at the level of the macular area. This pigment is composed of three carotenoids: lutein, zeaxanthin, meso-zeaxanthin. The first two compounds are of strictly food origin and are not produced in an endogenous way. A change of the macular pigment density and/or the quality of the macular pigment is suspected to play a role in the appearance and the evolution of the AMD. The food supplementation by corn with strong concentration in macular pigment could increase the density of the macular pigment. This could, in the future, represent a strategy of prevention of the AMD. The main objective of this study is to detect an increase of the macular pigment density after the consumption of this corn at healthy volunteers. The treatment will consist in a daily consumption of a box of 125g of corn with strong zeaxanthin content during 10 weeks. This corresponds to a daily contribution of at least 1,2 mg of lutein and 2,2 mg de zeaxanthin. After the inclusion visit, the subject will be seen 5 times (after 3, 6, 8, 10, 14 weeks of treatment). In all these visits, measures of the macular pigment will be realized. A blood sample will be realized at the inclusion visit and during the visit at 6 and 10 weeks.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 9
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Healthy volunteer Corn zeaxanthin -
- Primary Outcome Measures
Name Time Method The primary outcome is the measure of the evolution of the macular pigment density after 10 weeks of supplementation compared with the initial measure. 10 weeks after inclusion
- Secondary Outcome Measures
Name Time Method The measure of plasmatic rate of total cholesterol, HDL-cholesterol, triglycerides, lutein and zeaxanthin, initial and in 6 and 10 weeks of supplementation 10 weeks after inclusion In the inclusion, the measure of the retinal thickness with OCT (Optical Coherence Tomography) 10 weeks after inclusion The measure of the evolution of the plasmatic rate of zeaxanthin after10 weeks of supplementation 10 weeks after inclusion The measure of the macular pigment density before supplementation in 3, 6, 8, and 10 weeks of supplementation and after 4 weeks of stop by three methods: the sensibility in colours and two methods of autofluorescence 10 weeks after inclusion In the inclusion, the measure of the visual acuity and the examination of the fundus oculi. 10 weeks after inclusion
Trial Locations
- Locations (1)
CHU de Bordeaux
🇫🇷Bordeaux, France